Standard BioTools Inc
(NAS:LAB)
$
1.86
0.02 (1.09%)
Market Cap: 688.98 Mil
Enterprise Value: 318.60 Mil
PE Ratio: 0
PB Ratio: 1.23
GF Score: 75/100 - Q4 2023 Standard BioTools Inc Earnings Call TranscriptFeb 28, 2024$2.37 (+1.28%)Earnings
- Q3 2023 Standard BioTools Inc Earnings Call TranscriptNov 07, 2023$1.99 (-2.45%)Earnings
- Standard BioTools Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 16, 2023
- Q2 2023 Standard BioTools Inc Earnings Call TranscriptAug 08, 2023$2.38 (-0.83%)Earnings
- Standard BioTools Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Standard BioTools Inc Earnings Call TranscriptMay 09, 2023$1.6 (-3.33%)Earnings
- Standard BioTools Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) TranscriptMar 21, 2023
- Standard BioTools Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Q4 2022 Standard BioTools Inc Earnings Call TranscriptFeb 14, 2023$2.07 (-1.43%)Earnings
- Q3 2022 Standard BioTools Inc Earnings Call TranscriptNov 08, 2022$0.9804 (-2.93%)Earnings
- Q2 2022 Standard BioTools Inc Earnings Call TranscriptAug 08, 2022$2.04 (+7.94%)Earnings
- Q1 2022 Standard BioTools Inc Earnings Call TranscriptMay 05, 2022$3.01 (-3.83%)Earnings
- Fluidigm Corp at Piper Sandler Healthcare Conference (Virtual) Pre-recorded TranscriptNov 22, 2021
- Q3 2021 Fluidigm Corp Earnings Call TranscriptNov 08, 2021$4.82 (-1.23%)Earnings
- Fluidigm Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 28, 2021
- Q2 2021 Fluidigm Corp Earnings Call TranscriptAug 05, 2021$6.83 (-0.58%)Earnings
- Fluidigm Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Fluidigm Corp at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Fluidigm Corp Virtual Mass Cytometry Investor Day TranscriptMay 24, 2021
- Q1 2021 Fluidigm Corp Earnings Call TranscriptMay 06, 2021$4.59 (-5.94%)Earnings
- Fluidigm Corp at BTIG Virtual MedTech, Digital Health, Life Sciences, and Diagnostic Tools Conference TranscriptFeb 18, 2021
- Q4 2020 Fluidigm Corp Earnings Call TranscriptFeb 10, 2021$7.09 (+1.58%)Earnings
- Fluidigm Corp at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat TranscriptNov 24, 2020
- Fluidigm Corp at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Fluidigm Corp Earnings Call TranscriptNov 05, 2020$6.8 (+2.10%)Earnings
- Fluidigm Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Fluidigm Corp Earnings Call TranscriptAug 06, 2020$6.79 (-8.56%)Earnings
- Fluidigm Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Fluidigm Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Fluidigm Corp Earnings Call TranscriptMay 07, 2020$4.32 (+18.68%)Earnings
- Fluidigm Corp at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Fluidigm Corp at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Fluidigm Corp Earnings Call TranscriptFeb 10, 2020$3.71 (-2.11%)Earnings
- Fluidigm Corp at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- Q3 2019 Fluidigm Corp Earnings Call TranscriptNov 05, 2019$5.11 (-0.20%)Earnings
- Fluidigm Corp at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Fluidigm Corp Earnings Call TranscriptAug 01, 2019$12.15 (+3.40%)Earnings
- Fluidigm Corp at Jefferies Healthcare Conference TranscriptJun 04, 2019
- Fluidigm Corp at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Fluidigm Corp Earnings Call TranscriptMay 02, 2019$13.69 (+3.17%)Earnings
- Fluidigm Corp at Cowen Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Fluidigm Corp Earnings Call TranscriptFeb 07, 2019$8.55 (+0.94%)Earnings
Fluidigm Corp at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021 / 06:00PM GMT
Release Date Price:
$5.56
(-3.47%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Welcome. Dan Brennan on Day 2 of our Global Healthcare Conference for UBS. Really pleased to be joined with me here at 2:00 p.m. virtual presentation slot with Chris Linthwaite, CEO of Fluidigm. We might be having Vikram, CFO, join as well. We'll hear from them in a moment. But nonetheless, having Chris on stage with me, will be terrific, particularly following their event yesterday, their Investor Day and they're hosting, I believe, a user or a customer group meeting today. So maybe with that introduction, Chris, welcome.
Stephen Christopher Linthwaite
Fluidigm Corporation - President, CEO & Director
Thanks, Dan. I want just to thank you again for you and UBS for including us in your health care conference.
Questions & Answers
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Awesome. So series of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)